Literature DB >> 10200441

Retinoid-induced apoptosis in normal and neoplastic tissues.

L Nagy1, V A Thomazy, R A Heyman, P J Davies.   

Abstract

Vitamin A and its derivatives (collectively referred to as retinoids) are required for many fundamental life processes, including vision, reproduction, metabolism, cellular differentiation, hematopoesis, bone development, and pattern formation during embryogenesis. There is also considerable evidence to suggest that natural and synthetic retinoids have therapeutical effects due to their antiproliferative and apoptosis-inducing effects in human diseases such as cancer. Therefore it is not surprising that a significant amount of research was dedicated to probe the molecular and cellular mechanisms of retinoid action during the past decade. One of the cellular mechanisms retinoids have been implicated in is the initiation and modulation of apoptosis in normal development and disease. This review provides a brief overview of the molecular basis of retinoid signaling, and focuses on the retinoid-regulation of apoptotic cell death and gene expression during normal development and in pathological conditions in vivo and in various tumor cell lines in vitro.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10200441     DOI: 10.1038/sj.cdd.4400337

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  19 in total

1.  Inhibition of retinol oxidation by ethanol in the rat liver and colon.

Authors:  A Parlesak; I Menzl; A Feuchter; J C Bode; C Bode
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

2.  Paucity of retinoic acid receptor alpha (RAR alpha) nuclear immunostaining in gliomas and inability of retinoic acid to influence neural cell adhesion molecule (NCAM) expression.

Authors:  B K Kleinschmidt-DeMasters; E A Orr; E Savelieva; G C Owens; C A Kruse
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

Review 3.  A review of the molecular design and biological activities of RXR agonists.

Authors:  Nathalia Rodrigues de Almeida; Martin Conda-Sheridan
Journal:  Med Res Rev       Date:  2019-04-03       Impact factor: 12.944

4.  Opposing cytokine-specific effects of all trans-retinoic acid on the activation and expression of signal transducer and activator of transcription (STAT)-1 in THP-1 cells.

Authors:  Qiuyan Chen; Yifan Ma; A Catharine Ross
Journal:  Immunology       Date:  2002-10       Impact factor: 7.397

5.  Combined therapy with 131I and retinoic acid in Korean patients with radioiodine-refractory papillary thyroid cancer.

Authors:  So Won Oh; Seung-hwan Moon; Do Joon Park; Bo Youn Cho; Kyeong Cheon Jung; Dong Soo Lee; June-Key Chung
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-06-23       Impact factor: 9.236

6.  4-oxo-N-(4-hydroxyphenyl)retinamide: two independent ways to kill cancer cells.

Authors:  Paola Tiberio; Elena Cavadini; Gabriella Abolafio; Franca Formelli; Valentina Appierto
Journal:  PLoS One       Date:  2010-10-14       Impact factor: 3.240

7.  Retinoic acid regulates cell cycle progression and cell differentiation in human monocytic THP-1 cells.

Authors:  Qiuyan Chen; A Catharine Ross
Journal:  Exp Cell Res       Date:  2004-07-01       Impact factor: 3.905

8.  Maintenance therapy with 13-cis retinoid acid in high-grade glioma at complete response after first-line multimodal therapy--a phase-II study.

Authors:  Caecilia Wismeth; Peter Hau; Klaus Fabel; Ulrike Baumgart; Birgit Hirschmann; Horst Koch; Tanja Jauch; Oliver Grauer; Lisa Drechsel; Alexander Brawanski; Ulrich Bogdahn; Andreas Steinbrecher
Journal:  J Neurooncol       Date:  2004-05       Impact factor: 4.130

9.  Retinoic acid regulates CD1d gene expression at the transcriptional level in human and rodent monocytic cells.

Authors:  Qiuyan Chen; A Catharine Ross
Journal:  Exp Biol Med (Maywood)       Date:  2007-04

Review 10.  Transglutaminases: nature's biological glues.

Authors:  Martin Griffin; Rita Casadio; Carlo M Bergamini
Journal:  Biochem J       Date:  2002-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.